References

1. Data on file. Janssen Therapeutics, Division of Janssen Products, LP.
2. Katlama C, Haubrich R, Lalezari J, et al; on behalf of the DUET-1, DUET-2 study groups. Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. AIDS. 2009;23:2289-2300.